Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abbvie, admission, adolescent, adsorbent, alarming, Alnylam, Amsterdam, analogue, anxiety, Arena, Ariad, Bachelor, banker, bear, Benchmark, bile, Biomea, bloodstream, BNP, Boalt, border, Bulgaria, Canal, CEO, Chari, Chemotherapy, China, choice, circular, Commerzbank, CRE, Da, deadly, Delhi, depression, Diplom, discomfort, Divya, Doctor, Doctorate, Dohme, dominated, downregulation, DSCSA, Dublin, dynamic, economy, Elaine, Eli, Enterobacteriaceae, Erdtmann, ESBL, EuroQol, feature, Fortune, FPI, freely, fresh, Gilead, Grand, Hansraj, hear, heard, heightened, India, Indigo, ineffective, inseverable, interacting, Invitrogen, Kaufmann, lab, Lilly, LolCDE, Mahkam, Maky, Manmeet, Medtronic, mental, metabolome, MGB, mobility, Muenster, MZA, Network, oppose, outbreak, overview, pandemic, Plaza, presumptive, protracted, Pulse, quarantine, questionnaire, Rainer, Reata, reconsideration, regrowth, remanded, remotely, resell, Sharp, Shaun, societal, Sofia, Soni, spiked, spread, Spring, Stefanov, Stracker, strongly, Supreme, Sur, synthesized, Takeda, temporarily, unconstitutional, unlisted, unprovided, unreliable, urinary, Urology, VAS, Ventzislav, visual, Volterra, weather, wellbeing, Westfaelische, workshop, Wuhan, Zanganeh
Removed:
announce, announcement, arm, assuring, Axerion, BA, Barlow, bezolotoxumab, Bioaccelerate, biology, Bocconi, Brigham, Caldan, Catherine, Celldex, classification, Client, Commonwealth, concert, Connecticut, core, CuraGen, cystic, Dame, delist, depict, Deputy, Destiny, Dignity, dilute, dissolution, Diversified, DSCA, dual, Duke, Edinburgh, entice, Epidarex, extraordinary, Faculty, Faron, formally, Fulcrum, garnered, George, Hill, honorary, ICI, incompetence, indistinguishable, invited, join, Jonathan, JP, Juniper, KGaA, King, KPMG, land, lawyer, Lectureship, LLC, Lybrand, MedCity, medtech, Mereo, Morgan, negligence, Nogra, Notre, Ostrowski, overhead, Oy, PC, Peter, Polymer, postdoctoral, procuring, professor, promised, propose, psychology, Qardio, quoted, recapitalization, Reorganisation, Richard, Roden, Royal, running, Scotland, separation, Serono, spouse, St, standstill, Stephen, Stipendiary, straight, Stuart, Suisse, Swansea, Switzerland, tender, Treasurer, Turkey, unanimously, undertook, unusual, venture, Vertex, Women, Zeneca
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.7 Exhibit 2.7
- 4.3 Exhibit 4.3
- 4.24 Exhibit 4.24
- 4.29 Exhibit 4.29
- 4.30 Exhibit 4.30
- 4.31 Exhibit 4.31
- 4.32 Exhibit 4.32
- 4.33 Exhibit 4.33
- 4.34 Exhibit 4.34
- 4.35 Exhibit 4.35
- 4.36 Exhibit 4.36
- 4.37 Exhibit 4.37
- 8.1 Exhibit 8.1
- 12.1 Exhibit 12.1
- 12.2 Exhibit 12.2
- 13.1 Exhibit 13.1
- 15.1 Exhibit 15.1
- Download Excel data file
- View Excel data file
SMMT similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-224938 and No. 333-232074) of Summit Therapeutics plc of our report dated April 30, 2020 relating to the financial statements, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers LLP
Reading, United Kingdom
April 30, 2020